Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Regeneron expands agreement with HHS to develop treatments for 2019-nCoV

Feb. 5, 2020

Researchers cast wide net for rapid-draw weapons in 2019-nCoV fight

Feb. 5, 2020

SBIR grant supports Plex's development of antivirals for dengue, West Nile virus and Zika

Feb. 4, 2020

Anacor Pharmaceuticals synthesizes compounds for trypanosomiasis

Feb. 4, 2020

Gilead provides remdesivir for use in response to novel coronavirus

Feb. 3, 2020

Researchers develop an animal model of Marburg virus infection

Feb. 3, 2020

Adapting NGS for coronavirus surveillance

Feb. 3, 2020

Vaccitech presents data from the FLU009 phase II study of its VTP-100 vaccine

Feb. 3, 2020

CureVac and CEPI collaborate to develop vaccine against coronavirus nCoV-2019

Feb. 3, 2020

NHP model of Ebola virus infection via mucosal challenge

Feb. 3, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...